Results
26,520 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Friedman Paul ADirector |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $1.28M 2,432 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.28M 2,432 sh |
| Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.27M 2,450 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.06M 2,044 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.03M 1,996 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 19 | Howard Justyn RussellDirector, Executive Chair, 10% Owner |  SPTSprout Social, Inc.Open-market sale · 10b5-1 plan | SELL | $428K 40.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 18 | Rodman David MalcomChief Medical Officer |  MLYSMineralys Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $72K 2,170 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 18 | Gant Kelli K.See remarks |  HCCWARRIOR MET COAL, INC.Open-market sale · 10b5-1 plan | SELL | $1.00M 10.0K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 18 | Rodman David MalcomChief Medical Officer | MLYSMineralys Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $205K 6,348 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 18 | Baig SaqibChief Accounting Officer |  PTONPELOTON INTERACTIVE, INC.Open-market sale · 10b5-1 plan | SELL | $69K 10.0K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 17 | Ahn KennethPresident, Hagerty Marketplace |  HGTYHagerty, Inc.Open-market sale · 10b5-1 plan | SELL | $18K 1,350 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 17 | Susi Roger E.Director, CEO, PRESIDENT, CHAIRMAN, 10% Owner |  IRMDIRADIMED CORPOpen-market sale | SELL | $11K 112 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 16 | Stonehocker TimothyChief Technology Officer |  SOUNSOUNDHOUND AI, INC.Open-market sale · 10b5-1 plan | SELL | $356K 29.7K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $438K 840 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $692K 1,345 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $822K 1,560 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Brown Justin LPresident/Southwest Gas Corp. |  SWXSouthwest Gas Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $246K 3,028 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | McDonnell Kevin PatrickCFO |  AVAVAeroVironment IncOpen-market sale · 10b5-1 plan | SELL | $367K 999 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $366K 691 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $561K 1,066 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $480K 913 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $280K 539 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $493K 960 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $782K 1,489 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $482K 937 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $383K 732 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Vollero AndrewChief Financial Officer |  RDDTReddit, Inc.Open-market sale · 10b5-1 plan | SELL | $26K 100 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $814K 1,578 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $293K 554 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $700K 1,335 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $355K 681 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $304K 575 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $507K 970 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $628K 1,199 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $254K 473 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $440K 846 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $598K 1,135 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $269K 521 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $561K 1,094 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $396K 766 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Friedman Paul ADirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $707K 1,363 sh | Jan 13, 2026 traded Jan 9, 2026 |